One Ascent Financial Services LLC Collegium Pharmaceutical, Inc Transaction History

One Ascent Financial Services LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$14.22 - $20.88 $2,915 - $4,280	-205 Reduced 1.7%	11,872 $210,000
Q1 2022 May 12, 2022	BUY	$17.2 - $22.5 $5,211 - $6,817	303 Added 2.57%	12,077 $246,000
Q4 2021 Feb 08, 2022	BUY	$17.5 - $21.35 $10,710 - $13,066	612 Added 5.48%	11,774 $220,000
Q3 2021 Nov 12, 2021	BUY	$17.75 - $25.39 $47,658 - $68,172	2,685 Added 31.67%	11,162 $220,000
Q1 2021 Apr 27, 2021	SELL	$19.25 - $26.1 $247,112 - $335,045	-12,837 Reduced 60.23%	8,477 $201,000
Q4 2020 Jan 13, 2021	BUY	$17.83 - $22.29 $85,887 - $107,370	4,817 Added 29.2%	21,314 $427,000
Q3 2020 Nov 02, 2020	BUY	$15.78 - $20.82 $73,519 - $97,000	4,659 Added 39.36%	16,497 $343,000
Q2 2020 Jul 21, 2020	BUY	$15.49 - $23.51 $11,075 - $16,809	715 Added 6.43%	11,838 $207,000
Q1 2020 Apr 14, 2020	SELL	$13.89 - $25.45 $133,107 - $243,887	-9,583 Reduced 46.28%	11,123 $182,000
Q4 2019 Feb 11, 2020	BUY	$10.7 - $22.24 $221,554 - $460,501	20,706 New	20,706 $426,000
Q3 2019 Nov 15, 2019	SELL	$10.16 - $13.28 $212,222 - $277,392	-20,888 Closed	0 $0
Q2 2019 Aug 15, 2019	BUY	$10.62 - $16.59 $221,830 - $346,531	20,888 New	20,888 $275,000

254

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.12B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of One Ascent Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on One Ascent Financial Services LLC with notifications on news.